Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions ...

With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499/month or less, regardless of insurance status, under Zepbound Self Pay ...

Eli Lilly and Company (NYSE: LLY) today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single-dose vials for $499 per month ...

Eli Lilly and Company (NYSE: LLY) today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single-dose vials for $499 per month through ...

Learn More › Testing garden soil is the best way to determine what it needs—if anything—and how much. A variety of soil testing kits are available, but how reliable are they? Home gardeners rely on ...

Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States PR Newswire SEOUL, South Korea, Feb. 13, 2025 ...

A Connecticut man has pleaded guilty to tampering with and stealing Lorazepam vials at the hospital where he worked as a nurse, according to federal authorities. Sean Falzarano, 38, of Southbury ...

Heron Therapeutics Inc. announced its prior approval supplement application for the Zynrelef extended-release solution vial access needle has been approved by the FDA, according to a company press ...